Depressed school teacher hangs herself in classroom

Mangaluru, Jul 9: The coastal district of Dakshina Kannada today recorded death of two coronavirus patients.

Meanwhile, the district today also recorded 167 new covid cases taking the total number of cases to 1701.

Yesterday, the district had recorded 183 cases. Today more cases were reported from Bantwal and Ullal regions. 

According to sources, a 48-year-old man from Boloor, who was under treatment for covid-19 at designated covid hospital passed away today. 

A 62-year-old covid patient, who had SARI symptoms, breathed his last at a private hospital.

With this, the total number of deaths of covid-19 patients in the district reached 30 including two deaths caused by other reasons.

Of the 167 who tested positive on Thursday, 110 are males and 57 females including seven children.

Three have returned from Qatar and Dubai, one from Bengaluru, 42 are diagnosed with influenza-like illness (ILI), six are diagnosed with severe acute respiratory illness (SARI) and 64 are primary contacts of earlier patients. Contact tracing process of 38 patients is on, and 13 pre-surgery samples.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Udupi, Jan 5: The district administration has identified 460 beneficiaries who will be allotted flats at Herga under the Pradhan Mantri Awas Yojana, informed MLA Raghupati Bhat.

Speaking to reporters here on Sunday he said the Udupi Municipal Council will construct the apartments in the 8.22 acres of land earmarked for the purpose at Herga. The flats will be ready before April 2021.